A strong message is needed to address the issue of HCC recurrence after DAA therapy

Posté sur 12 novembre 2019 par FSCCF

Kolly P, Dufour JF. J Hepatol. 2016 Dec;65(6):1268-1269. doi: 10.1016/j.jhep.2016.07.032. Epub 2016 Jul 29. No abstract available.